Michael J. Farrell sold $2.0M of RMD
Chairman and CEO at RESMED INC. 8,011 shares at an average of $249.75, traded Nov 7, 2025, filed Nov 10, 2025.
Score components
- +25RoleCEO
- +25Trade size$2.0M at market
- 0Share of holdings soldSold 1.7% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000943819-25-000095, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 7, 2025 | MOption exercise ResMed Common Stock10b5-1 | +983 | $101.64 | $100k | 468,849 | Nov 10, 2025 |
| Nov 7, 2025 | MOption exercise ResMed Common Stock10b5-1 | +7,028 | $101.64 | $714k | 475,877 | Nov 10, 2025 |
| Nov 7, 2025 | SOpen-market sale ResMed Common Stock10b5-1 | -8,011 | $249.75 | $2.0M | 467,866 | Nov 10, 2025 |
| Nov 7, 2025 | MOption exercise ResMed Common Stock Optionsderivative10b5-1 | -983 | $0.00 | $0 | 7,028 | Nov 10, 2025 |
| Nov 7, 2025 | MOption exercise ResMed Common Stock Optionsderivative10b5-1 | -7,028 | $0.00 | $0 | 0 | Nov 10, 2025 |
Related signals
Other insiders at RESMED INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | RESMED INC | Michael J. Farrell Chairman and CEO | $1.1M 4,991 shares | -1% | |
| 23Weak | RESMED INC | Michael J. Farrell Chairman and CEO | $1.1M 4,991 shares | -1% | |
| 16Weak | RESMED INC | Peter C Farrell director | $228k 970 shares | -2% | |
| 23Weak | RESMED INC | Michael J. Farrell Chairman and CEO | $1.3M 4,991 shares | -1% | |
| 21Weak | RESMED INC | Peter C Farrell director | $520k 2,000 shares | -3% | |
| 23Weak | RESMED INC | Michael J. Farrell Chairman and CEO | $1.4M 4,991 shares | -1% | |
| 21Weak | RESMED INC | Peter C Farrell director | $503k 2,000 shares | -3% | |
| 21Weak | RESMED INC | Peter C Farrell director | $498k 2,000 shares | -3% | |
| 23Weak | RESMED INC | Michael J. Farrell Chairman and CEO | $1.2M 4,991 shares | -1% | |
| 30Weak | RESMED INC | Michael J. Farrell Chairman and CEO | $1.3M 4,991 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.